MedTrace Logo

The Effect of Diabetes Mellitus on the Prognosis of Patients With COVID-19

NCT04591704 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2021-05-04

No results posted yet for this study

Summary

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study.

The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Conditions

Interventions

OTHER

hospitalisation, necessity of ICU, mortality rate, lung involvement

hospitalisation, necessity of ICU, mortality rate, lung involvement

Sponsors & Collaborators

  • Uşak University

    lead OTHER

Principal Investigators

  • Cevdet Duran · Uşak Üniversitesi Tıp fak

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-20
Primary Completion
2020-10-15
Completion
2021-07-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04591704 on ClinicalTrials.gov